Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Mitomycin C Market Trend and Forecast to 2022

  • QYR1202209
  • 124 Pages
  • May 2017
  • Healthcare
Download Sample    Get Discount   
 
This report studies the Mitomycin C market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Mitomycin C market by product type and applications/end industries.

In the last several years, Global market of Mitomycin C was experienced an upward trend rapidly, with an average growth rate of 4.76%. In 2016, Global Revenue of Mitomycin C is nearly 119.83 M USD; the actual production is about 17370 K Unit.

The major players in global Mitomycin C market include

Kyowa-kirin

Intas Pharmaceuticals

Teva

Bristol-Myers Squibb

Aspen

Speciality European Pharma

Alkem Laboratories

Varifarma

APOGEPHA

Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Mitomycin C in these regions, from 2012 to 2022 (forecast), covering

Europe

North America

India

Japan

Other

On the basis of product, the Mitomycin C market is primarily split into

2 Mg

10 Mg

40 Mg

Other

On the basis on the end users/applications, this report covers

Cancer Treatment

Ophthalmic Use

Others

Table of Contents

1 Mitomycin C Market Overview 1

1.1 Product Overview and Scope of Mitomycin C 1

1.2 Mitomycin C Segment by Types 2

1.2.1 Mitomycin C Segment by Types 2

1.2.2 Global Mitomycin C Production Market Share by Types in 2016 2

1.2.3 2 Mg 3

1.2.4 10 Mg 3

1.2.5 40 Mg 4

1.3 Global Mitomycin C Segment by Applications 4

1.3.1 Global Mitomycin C Segment by Applications 4

1.3.2 Cancer Treatment 5

1.3.3 Ophthalmic Use 6

1.4 Global Mitomycin C Market by Regions (2012-2022) 7

1.4.1 North America Mitomycin C Status and Prospect (2012-2022) 7

1.4.2 India Mitomycin C Status and Prospect (2012-2022) 8

1.4.3 Europe Mitomycin C Status and Prospect (2012-2022) . 8

1.4.4 Japan Mitomycin C Status and Prospect (2012-2022) 9

1.5 Global Mitomycin C Market Size (2012-2022) 10

1.5.1 Global Mitomycin C Revenue Status and Outlook (2012-2022) 10

1.5.2 Global Mitomycin C Production Status and Outlook (2012-2022) 11

2 Global Mitomycin C Market Competition by Manufacturers 12

2.1 Global Mitomycin C Production and Share by Manufacturers (2016-2017) 12

2.2 Global Mitomycin C Revenue and Share by Manufacturers (2016-2017) 14

2.3 Global Mitomycin C Average Price by Manufacturers (2016-2017) 16

2.4 Manufacturers Mitomycin C Headquarters and Establish Date 17

2.5 Mitomycin C Market Competitive Situation and Trends 17

2.5.1 Mitomycin C Market Concentration Rate 17

2.5.2 Mitomycin C Market Share of Top 3 and Top 5 Manufacturers 18

2.5.3 Mergers & Acquisitions, Expansion 19

3 Global Mitomycin C Production by Regions (2012-2017) 20

3.1 Global Mitomycin C Production and Market Share by Regions (2012-2017) 20

3.2 Global Mitomycin C Revenue and Market Share by Regions (2012-2017) 22

3.3 Global Mitomycin C Production Revenue, Price and Gross Margin (2012-2017) 24

3.4 North America Mitomycin C Production (2012-2017) 25

3.4.1 North America Mitomycin C Production and Growth Rate (2012-2017) 25

3.4.2 North America Mitomycin C Production, Revenue, Price and Gross Margin (2012-2017) 25

3.5 Europe Mitomycin C Production (2012-2017) 26

3.5.1 Europe Mitomycin C Production and Growth Rate (2012-2017) 26

3.5.2 Europe Mitomycin C Production, Revenue, Price and Gross Margin (2012-2017) 26

3.6 India Mitomycin C Production (2012-2017) 27

3.6.1 India Mitomycin C Production and Growth Rate (2012-2017) 27

3.6.2 India Mitomycin C Production, Revenue, Price and Gross Margin (2012-2017) 27

3.7 Japan Mitomycin C Production (2012-2017) 28

3.7.1 Japan Mitomycin C Production and Growth Rate (2012-2017) 28

3.7.2 Japan Mitomycin C Production, Revenue, Price and Gross Margin (2012-2017) 28

4 Global Mitomycin C Consumption (K Unit) by Regions (2012-2017) 30

4.1 Global Mitomycin C Consumption by Regions (2012-2017) 30

4.2 North America Mitomycin C Consumption (2012-2017) 32

4.3 Europe Mitomycin C Consumption (2012-2017) 33

4.4 China Mitomycin C Consumption (2012-2017) 33

4.5 Japan Mitomycin C Consumption (2012-2017) 34

4.6 India Mitomycin C Consumption (2012-2017) 34

5 Global Mitomycin C Production, Revenue, Price Trend by Types 35

5.1 Global Mitomycin C Production and Market Share by Types (2012-2017) 35

5.2 Global Mitomycin C Revenue and Market Share by Types (2012-2017) 37

5.3 Global Mitomycin C Price by Type (2012-2017) 38

5.4 Global Mitomycin C Production Growth by Type (2012-2017) 39

6 Global Mitomycin C Market Analysis by Applications 40

6.1 Global Mitomycin C Consumption and Market Share by Applications (2012-2017) 40

6.2 Global Mitomycin C Consumption Growth Rate by Applications (2012-2017) 42

7 Analysis of Mitomycin C Industry Key Manufacturers 43

7.1 Kyowa-kirin 43

7.1.1 Company Profile 43

7.1.2 Product Information 44

7.1.3 Production, Price, Cost, Gross, and Revenue 44

7.2 Intas Pharmaceuticals 45

7.2.1 Company Profile 45

7.2.2 Product Information 47

7.2.3 Production, Price, Cost, Gross, and Revenue 47

7.3 Teva 48

7.3.1 Company Profile 48

7.3.2 Product Information 49

7.3.3 Production, Price, Cost, Gross, and Revenue 49

7.4 Bristol-Myers Squibb 50

7.4.1 Company Profile 50

7.4.2 Product Information 51

7.4.3 Production, Price, Cost, Gross, and Revenue 51

7.5 Aspen 52

7.5.1 Company Profile 52

7.5.2 Product Information 53

7.5.3 Production, Price, Cost, Gross, and Revenue 53

7.6 Speciality European Pharma 54

7.6.1 Company Profile 54

7.6.2 Product Information 55

7.6.3 Production, Price, Cost, Gross, and Revenue 55

7.7 Alkem Laboratories 56

7.7.1 Company Profile 56

7.7.2 Product Information 57

7.7.3 Production, Price, Cost, Gross, and Revenue 57

7.8 Varifarma 58

7.8.1 Company Profile 58

7.8.2 Product Information 59

7.8.3 Production, Price, Cost, Gross, and Revenue 59

7.9 APOGEPHA 59

7.9.1 Company Profile 59

7.9.2 Product Information 61

7.9.3 Production, Price, Cost, Gross, and Revenue 61

8 Mitomycin C Manufacturing Cost Analysis 62

8.1 Mitomycin C Key Raw Materials Analysis 62

8.1.1 Key Raw Materials 62

8.1.2 Key Suppliers of Raw Materials 62

8.2 Proportion of Manufacturing Cost Structure 64

8.2.1 Raw Materials 64

8.2.2 Labor Cost 64

8.2.3 Manufacturing Expenses 69

8.3 Manufacturing Process Analysis of Mitomycin C 69

9 Industrial Chain, Sourcing Strategy and Downstream Buyers 70

9.1 Mitomycin C Industrial Chain Analysis 70

9.2 Upstream Raw Materials Sourcing 71

9.3 Downstream Buyers 71

10 Marketing Strategy Analysis, Distributors/Traders 74

10.1 Marketing Channel 74

10.1.1 Direct Marketing 74

10.1.2 Indirect Marketing 74

10.1.3 Marketing Channel Development Trend 74

10.2 Market Positioning 75

10.2.1 Pricing Strategy 75

10.2.2 Brand Strategy 76

10.2.3 Target Client 77

10.3 Distributors/Traders List 78

11 Market Effect Factors Analysis 80

11.1 Technology Progress/Risk 80

11.1.1 Substitutes Threat 80

11.1.2 Technology Progress in Related Industry 82

11.2 Consumer Needs/Customer Preference Change 85

11.3 Economic/Political Environmental Change 86

12 Global Mitomycin C Market Forecast (2017-2022) 94

12.1 Global Mitomycin C Production, Revenue Forecast (2017-2022) 94

12.1.1 Global Mitomycin C Production and Growth Rate Forecast (2017-2022) 94

12.1.2 Global Mitomycin C Revenue and Growth Rate Forecast (2017-2022) 95

12.1.3 Global Mitomycin C Price and Trend Forecast (2017-2022) 96

12.2 Global Mitomycin C Production Forecast by Regions (2017-2022) 96

12.3 Global Mitomycin C Consumption Forecast by Regions (2017-2022) 97

12.3.1 North America Mitomycin C Consumption Forecast (2017-2022) 98

12.3.2 Europe Mitomycin C Consumption Forecast (2017-2022) 99

12.3.3 China Mitomycin C Consumption Forecast (2017-2022) 100

12.3.4 Japan Mitomycin C Consumption Forecast (2017-2022) 101

12.3.5 India Mitomycin C Consumption Forecast (2017-2022) 102

12.4 Global Mitomycin C Production and Revenue Forecast by Type (2017-2022) 102

12.5 Global Mitomycin C Consumption Forecast by Application (2017-2022) 104

13 Research Findings and Conclusion 106

14 Methodology and Data Source 107

14.1 Methodology/Research Approach 107

14.1.1 Research Programs/Design 107

14.1.2 Market Size Estimation 108

14.2 Data Source 110

14.2.1 Secondary Sources 110

14.2.2 Primary Sources 111

14.3 Disclaimer 112

14.4 Author List 113

List of Tables and Figures

Figure Product Picture of Mitomycin C 1

Table Mitomycin C Segment by Types 2

Figure Global Mitomycin C Production Market Share by Types in 2016 2

Figure Product Picture of 2 Mg 3

Figure Product Picture of 10 Mg 3

Figure Product Picture of 40 Mg 4

Table Global Mitomycin C Segment by Applications 4

Figure Global Mitomycin C Consumption (K Unit) Market Share by Applications in 2016 5

Figure Cancer Treatment Examples 5

Figure Ophthalmic Use Examples 6

Figure North America Mitomycin C Revenue (M USD) and Growth Rate (2012-2022) 7

Figure India Mitomycin C Revenue (M USD) and Growth Rate (2012-2022) 8

Figure Europe Mitomycin C Revenue (M USD) and Growth Rate (2012-2022) 8

Figure Japan Mitomycin C Revenue (M USD) and Growth Rate (2012-2022) 9

Figure Global Mitomycin C Revenue Status and Outlook (2012-2022) 10

Figure Global Mitomycin C Production Status and Outlook (2012-2022) 11

Table Global Mitomycin C Production (K Unit) of Key Manufacturers (2016-2017) 12

Table Global Mitomycin C Production Share by Manufacturers (2016-2017) 12

Figure 2016 Mitomycin C Production Share by Manufacturers 13

Figure 2017 Mitomycin C Production Share by Manufacturers 13

Table Global Mitomycin C Revenue (M USD) by Manufacturers (2016-2017) 14

Table Global Mitomycin C Revenue Share by Manufacturers (2016-2017) 14

Figure 2016 Global Mitomycin C Revenue Share by Manufacturers 15

Figure 2017 Global Mitomycin C Revenue Share by Manufacturers 15

Table Global Market Mitomycin C Average Price (USD/Unit) of Key Manufacturers (2016-2017) 16

Figure Global Market Mitomycin C Average Price (USD/Unit) of Key Manufacturers in 2016 16

Table Manufacturers Mitomycin C Headquarters and Establish Date 17

Table Global Mitomycin C Production Share by Manufacturers (2016-2017) 17

Figure Mitomycin C Production Market Share of Top 3 Manufacturers 18

Figure Mitomycin C Production Market Share of Top 5 Manufacturers 18

Table Global Mitomycin C Production (K Unit) by Regions (2012-2017) 20

Table Global Mitomycin C Production Market Share by Regions (2012-2017) 20

Figure Global Mitomycin C Production Market Share by Regions (2012-2017) 21

Figure 2016 Global Mitomycin C Production Market Share by Regions 21

Table Global Mitomycin C Revenue (M USD) by Regions (2012-2017) 22

Table Global Mitomycin C Revenue Market Share by Regions (2012-2017) 22

Figure Global Mitomycin C Revenue Market Share by Regions (2012-2017) 22

Figure 2016 Global Mitomycin C Revenue Market Share by Regions 23

Figure Global Mitomycin C Production (K Unit) and Growth Rate (2012-2017) 24

Table Global Mitomycin C Production (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017) 24

Figure North America Mitomycin C Production (K Unit) and Growth Rate (2012-2017) 25

Table North America Mitomycin C Production (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017) 25

Figure Europe Mitomycin C Production (K Unit) and Growth Rate (2012-2017) 26

Table Europe Mitomycin C Production (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017) 26

Figure India Mitomycin C Production (K Unit) and Growth Rate (2012-2017) 27

Table India Mitomycin C Production (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017) 27

Figure Japan Mitomycin C Production (K Unit) and Growth Rate (2012-2017) 28

Table Japan Mitomycin C Production (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017) 28

Table Global Mitomycin C Consumption (K Unit) Market by Regions (2012-2017) 30

Table Global Mitomycin C Consumption Market Share by Regions (2012-2017) 30

Figure Global Mitomycin C Consumption Market Share by Regions (2012-2017) 31

Figure 2016 Global Mitomycin C Consumption Market Share by Regions 31

Figure North America Mitomycin C Consumption (K Unit) and Growth Rate (2012-2017) 32

Figure Europe Mitomycin C Consumption (K Unit) and Growth Rate (2012-2017) 33

Figure China Mitomycin C Consumption (K Unit) and Growth Rate (2012-2017) 33

Figure Japan Mitomycin C Consumption (K Unit) and Growth Rate (2012-2017) 34

Figure India Mitomycin C Consumption (K Unit) and Growth Rate (2012-2017) 34

Table Global Mitomycin C Production (K Unit) by Types (2012-2017) 35

Table Global Mitomycin C Production Share by Types (2012-2017) 35

Figure Production Market Share of Mitomycin C by Types (2012-2017) 36

Figure 2016 Production Market Share of Mitomycin C by Types 36

Table Global Mitomycin C Revenue (M USD) by Types (2012-2017) 37

Table Global Mitomycin C Revenue Share by Types (2012-2017) 37

Figure Revenue Share of Mitomycin C by Types (2012-2017) 37

Figure 2016 Revenue Market Share of Mitomycin C by Types 38

Table Global Mitomycin C Price (USD/Unit) by Types (2012-2017) 38

Figure Global Mitomycin C Production Growth by Type (2012-2017) 39

Table Global Mitomycin C Consumption (K Unit) by Applications (2012-2017) 40

Table Global Mitomycin C Consumption Market Share by Applications (2012-2017) 40

Figure Global Mitomycin C Consumption Market Share by Applications (2012-2017) 41

Figure Global Mitomycin C Consumption Market Share by Applications in 2016 41

Table Global Mitomycin C Consumption Growth Rate by Applications (2012-2017) 42

Figure Global Mitomycin C Consumption Growth Rate by Applications (2012-2017) 42

Table Kyowa-kirin Company Profile 43

Figure Mitomycin C Product Picture of Kyowa-kirin 44

Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Kyowa-kirin 2016-2017 44

Table Intas Pharmaceuticals Company Profile 45

Figure Mitomycin C Product Picture of Intas Pharmaceuticals 47

Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Intas Pharmaceuticals 2016-2017 47

Table Teva Company Profile 48

Figure Mitomycin C Product Picture of Teva 49

Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva 2016-2017 49

Table Bristol-Myers Squibb Company Profile 50

Figure Mitomycin C Product Picture of Bristol-Myers Squibb 51

Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2016-2017 51

Table Aspen Company Profile 52

Figure Mitomycin C Product Picture of Aspen 53

Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Aspen 2016-2017 53

Table Speciality European Pharma Company Profile 54

Figure Mitomycin C Product Picture of Speciality European Pharma 55

Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Speciality European Pharma 2016-2017 55

Table Alkem Laboratories Company Profile 56

Figure Mitomycin C Product Picture of Alkem Laboratories 57

Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Alkem Laboratories 2016-2017 57

Table Varifarma Company Profile 58

Figure Mitomycin C Product Picture of Varifarma 59

Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Varifarma 2016-2017 59

Table APOGEPHA Company Profile 59

Figure Mitomycin C Product Picture of APOGEPHA 61

Table Mitomycin C Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of APOGEPHA 2016-2017 61

Table Key Raw Materials 62

Table Key Suppliers of Raw Materials 62

Figure Manufacturing Cost Structure of Mitomycin C 64

Figure USA Labor Cost Analysis 2012-2016 65

Figure Cost of Employing a Factory Worker 66

Figure 2016 Estimated Labour Costs for the Whole Economy in Europe 67

Figure Monthly Minimum Wages in Asia 2016 68

Figure China Labor Costs 2013-2016 68

Figure Manufacturing Process Analysis of Mitomycin C 69

Figure Mitomycin C Industrial Chain Analysis 70

Table Major Buyers of Mitomycin C 71

Figure Setting Pricing Policy 75

Table Distributors/Traders List 78

Figure Growth of the Late Phase Oncology Pipeline, 2005-2015 82

Figure Key In-Market and Investigational Agents for NSCLC 83

Figure Key In-Market and Investigational Agents for Melanoma 83

Figure the Global Late Phase Oncology Pipeline in 2015 84

Figure Companies with Active Late Phase Oncology Pipelines 85

Figure Global GDP Growth Rate for 2016 86

Figure US GDP 2006-2016 (Billion USD) 87

Figure US CPI Change 2016-2017 87

Figure EU GDP 2006-2016 (Billion USD) 88

Figure EU CPI Change 2012-2016 88

Figure Germany GDP 2006-2016 (Billion USD) 89

Figure UK GDP 2006-2016 (Billion USD) 89

Figure UK CPI Change 2016-2017 90

Figure Italy GDP 2006-2016 (Billion USD) 90

Figure Italy CPI Change 2016-2017 91

Figure Japan GDP 2006-2016 (Billion USD) 91

Figure Japan CPI Change 2012-2016 92

Figure China GDP 2006-2016 (Billion USD) 92

Figure China CPI Change 2016-2017 93

Figure Global Mitomycin C Production (K Unit) and Growth Rate Forecast (2017-2022) 94

Figure Global Mitomycin C Revenue (M USD) and Growth Rate Forecast (2017-2022) 95

Figure Global Mitomycin C Price (USD/Unit) and Trend Forecast (2017-2022) 96

Table Global Mitomycin C Production (K Unit) Forecast by Regions (2017-2022) 96

Figure Global Mitomycin C Production Market Share Forecast by Regions (2017-2022) 97

Table Global Mitomycin C Consumption (K Unit) Forecast by Regions (2017-2022) 97

Figure Global Mitomycin C Consumption Market Share Forecast by Regions (2017-2022) 98

Figure North America Mitomycin C Consumption (K Unit) and Growth Rate Forecast (2017-2022) 98

Figure Europe Mitomycin C Consumption (K Unit) and Growth Rate Forecast (2017-2022) 99

Figure China Mitomycin C Consumption (K Unit) and Growth Rate Forecast (2017-2022) 100

Figure Japan Mitomycin C Consumption (K Unit) and Growth Rate Forecast (2017-2022) 101

Figure India Mitomycin C Consumption (K Unit) and Growth Rate Forecast (2017-2022) 102

Table Global Mitomycin C Production (K Unit) Forecast by Type (2017-2022) 102

Figure Global Mitomycin C Production Forecast by Type (2017-2022) 103

Table Global Mitomycin C Revenue (M USD) Forecast by Type (2017-2022) 103

Figure Global Mitomycin C Revenue Market Share Forecast by Type (2017-2022) 104

Table Global Mitomycin C Consumption (K Unit) Forecast by Application (2017-2022) 104

Figure Global Mitomycin C Consumption Forecast by Application (2017-2022) 105

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950